作者: Xiaoke Guo , Qian Yang , Jing Xu , Li Zhang , Hongxi Chu
DOI: 10.1016/J.BMC.2013.08.041
关键词:
摘要: Atrial fibrillation (AF) is one of the common arrhythmias that threaten human health. Kv1.5 potassium channel reported as an efficacious and safe target for treatment AF. In this paper, we designed synthesized three series compounds through modifying lead compound RH01617 was screened out by pharmacophore model earlier. All were evaluated whole-patch lamp technology most them possessed potent inhibitory activities against Kv1.5. Compounds IIIi IIIl selectivity well pharmacodynamic effects in isolated rat model. Due to promising pharmacological behavior, deserves further pharmacokinetic evaluations.